Gut Microbiota in T1DM-Onset Pediatric Patients: Machine-Learning Algorithms to Classify Microorganisms as Disease...

Area of Science:

• Microbiome research
• Pediatric endocrinology
• Metabolic disease

Background:

• Type 1 diabetes (T1D) is an autoimmune disease affecting children.
• The gut microbiome plays a role in immune system development and metabolic regulation.
• Understanding T1D-associated gut microbial changes is crucial for potential therapeutic strategies.

Purpose of the Study:

• To identify the unique gut microbial fingerprint in pediatric patients with T1D.
• To compare the gut microbiome composition of children with T1D at onset versus healthy children.

Main Methods:

• 16S ribosomal RNA gene sequencing was used to analyze the microbiome of 31 children with T1D and 25 healthy children.
• Machine-learning and metagenome functional analyses were employed to identify significant microbial taxa and metabolic pathways.

Main Results:

• Children with T1D exhibited higher levels of Bacteroides stercoris, Bacteroides fragilis, Bifidobacterium bifidum, Gammaproteobacteria, Holdemania, and Synergistetes.
• Conversely, Bacteroides vulgatus, Parasutterella, Lactobacillus, and Turicibacter were less abundant in T1D patients.
• Predicted metabolic pathways associated with T1D included carbon metabolism, sugar metabolism, and iron metabolism.
• Clinical factors like BMI, autoantibodies, glycemia, HbA1c, and age at onset correlated with specific microbial clusters.

Conclusions:

• The study confirms the distinct gut microbial composition in pediatric T1D patients, highlighting the importance of Bacteroides stercoris and Synergistetes.
• These findings underscore the value of multi-region sequencing and diverse analytical approaches for microbiome studies.